Abstract
To investigate whether autologous cell therapy using CD133+ bone marrow derived stem cells (BMDSc) improve endometrial thickness and clinical results in patients with refractory Asherman's syndrome (AS) or endometrial atrophy (EA).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
